Alopecia After Switch to Tenofovir Alafenamide in Six African American Women

    June 2019 in “ Open Forum Infectious Diseases ”
    Said El Zein, Hussam Tabaja, Amjad Kanj, Deborah Richmond, Jennifer Veltman
    Image of study
    TLDR Six African American women experienced hair loss after switching to a new HIV medication.
    In a June 2019 case series, six African American women aged 40 to 61 developed alopecia after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) for HIV treatment. The hair loss occurred within 2 months to 1 year after the switch, with most cases happening within 2-4 months. No other causes for the hair loss were identified. After switching to alternative antiretroviral therapies, two patients experienced hair regrowth and three reported subjective improvement. The study suggests a potential link between TAF and alopecia and underscores the importance of including diverse populations in clinical trials to identify possible side effects. The study did not receive financial support, and one author had potential conflicts of interest. Verbal consent was obtained from the patients, and the data collection was approved by an Institutional Review Board.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 3 months ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Androgenic alopecia exclusively on the vertex of the scalp

      in Chat  6 upvotes 4 months ago
      A user experienced androgenic alopecia starting at the vertex without frontal hairline recession and is seeking information on this pattern. Another user noted that vertex or diffuse hair loss is common among men.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 6 months ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  64 upvotes 11 months ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

      community Caffeine & Alopecia: What the Science Seems to Say

      in Research/Science  17 upvotes 1 year ago
      The conversation discusses the potential benefits of topical caffeine for Androgenetic Alopecia (APA) and female pattern hair loss. While some studies suggest positive results, there's no reliable scientific evidence to strongly recommend caffeine compounds for hair regrowth.

    Related Research

    1 / 1 results